Wednesday, 18 April 2018 ()
The Food and Drug Administration's approval would technically limit the treatment to a small group of epilepsy patients.
Wednesday, 18 April 2018 ()
The Food and Drug Administration's approval would technically limit the treatment to a small group of epilepsy patients.| 0 shares | |